Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell Therapeutics – Genetic Engineering & Biotechnology News
Medical Xpress |
Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell Therapeutics
Genetic Engineering & Biotechnology News The University of California, Irvine team, led by professor Weian Zhao, associate professor of pharmaceutical sciences, hopes that stiffness-targeting MSCs, and potentially other engineered cell types including CAR T-cells, could be developed to treat … Stem cell therapy attacks cancer by targeting unique tissue stiffnessMedical Xpress |
KERA News |
Debilitating Muscular Disease Common In Boys Could Be Curbed By Rewriting Genetic Code
KERA News [KERA followed Chance Hawkins, who has the disease, in its American Graduate series, Class of ’17.] Eric Olson, chairman of the molecular biology department at UT Southwestern explains how CRISPR technology allows scientists to rewrite genetic code, … |
MIT Technology Review |
A First-of-a-Kind Gene Therapy Cure Has Struggled to Find a Market
MIT Technology Review GSK’s decision to offload Strimvelis, as well as two other experimental gene therapies that have not yet been approved, highlights how challenging it has been to market complex, ultra-costly genetic treatments designed to help tiny groups of patients. GSK gives up on rare diseases as gene therapy gets two customersReuters |
The Scientist |
UCI stem cell therapy attacks cancer by targeting unique tissue stiffness
UCI News Irvine, Calif., July 26, 2017 — A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in … Tumor Tissue Stiffness Exploited for MSC or Potentially CAR T-Cell TherapeuticsGenetic Engineering & Biotechnology News |